Link to this page
Medical Subject Headings
| Id | http://purl.bioontology.org/ontology/MESH/D016023
http://purl.bioontology.org/ontology/MESH/D016023
|
|---|---|
| Preferred Name | Integrins |
| Definitions |
A family of transmembrane glycoproteins (MEMBRANE GLYCOPROTEINS) consisting of noncovalent heterodimers. They interact with a wide variety of ligands including EXTRACELLULAR MATRIX PROTEINS; COMPLEMENT, and other cells, while their intracellular domains interact with the CYTOSKELETON. The integrins consist of at least three identified families: the cytoadhesin receptors (RECEPTORS, CYTOADHESIN), the leukocyte adhesion receptors (RECEPTORS, LEUKOCYTE ADHESION), and the VERY LATE ANTIGEN RECEPTORS. Each family contains a common beta-subunit (INTEGRIN BETA CHAINS) combined with one or more distinct alpha-subunits (INTEGRIN ALPHA CHAINS). These receptors participate in cell-matrix and cell-cell adhesion in many physiologically important processes, including embryological development; HEMOSTASIS; THROMBOSIS; WOUND HEALING; immune and nonimmune defense mechanisms; and oncogenic transformation.
|
| Synonyms |
Integrin
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A family of transmembrane glycoproteins (MEMBRANE GLYCOPROTEINS) consisting of noncovalent heterodimers. They interact with a wide variety of ligands including EXTRACELLULAR MATRIX PROTEINS; COMPLEMENT, and other cells, while their intracellular domains interact with the CYTOSKELETON. The integrins consist of at least three identified families: the cytoadhesin receptors (RECEPTORS, CYTOADHESIN), the leukocyte adhesion receptors (RECEPTORS, LEUKOCYTE ADHESION), and the VERY LATE ANTIGEN RECEPTORS. Each family contains a common beta-subunit (INTEGRIN BETA CHAINS) combined with one or more distinct alpha-subunits (INTEGRIN ALPHA CHAINS). These receptors participate in cell-matrix and cell-cell adhesion in many physiologically important processes, including embryological development; HEMOSTASIS; THROMBOSIS; WOUND HEALING; immune and nonimmune defense mechanisms; and oncogenic transformation. |
|---|---|
| altLabel | Integrin
|
| prefLabel | Integrins
|
| Machine permutation | 90
|
| HN | 90
|
| Mapped from |
See more
See less
|
| type | |
| tui |
T116
T129
T192
|
| TERMUI |
T047571
T000996175
|
| TH |
NLM (1990)
NLM (2021)
|
| MMR | 20210630
|
| notation | D016023
|
| Inverse of RO | |
| Semantic type UMLS property | |
| Inverse of AQ |
See more
See less
|
| FX | D015815
|
| DX | 19900101
|
| cui | C0021701
|
| DC | 1
|
| MN | D12.776.543.750.705.408
|
| AN | prefer specifics
|
| AQL | AD AG AI AN BI BL CF CH CL DE DF GE HI IM IP ME PH RE TU UL
|
| Inverse of RB | 0
|
| MDA | 19990101
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |